TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Beta-Elemene, Temozolomide
Phytochemical Name Beta-Elemene (PubChem CID: 6918391 )
Anticancer drug Name Temozolomide (PubChem CID: 5394 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 707
Pair Name Beta-Elemene, Temozolomide
Disease Info [ICD-11: 2A00] Glioblastoma multiforme Investigative
Gene Regulation Down-regulation Expression AKT1 hsa207
Down-regulation Phosphorylation ATM hsa472
Down-regulation Expression H2AX hsa3014
Down-regulation Expression MAPK3 hsa5595
In Vitro Model U-87MG ATCC Glioblastoma Homo sapiens (Human) CVCL_0022
T98G Glioblastoma Homo sapiens (Human) CVCL_0556
U-251MG Astrocytoma Homo sapiens (Human) CVCL_0021
LN-229 Glioblastoma Homo sapiens (Human) CVCL_0393
C6 Rat malignant glioma Rattus norvegicus (Rat) CVCL_0194
Result These results revealed that β-elemene could significantly increase the radiosensitivity and chemosensitivity of GBM. β-elemene may be used as a potential drug in combination with the radiotherapy and chemotherapy of GBM
03. Reference
No. Title Href
1 β-elemene enhances both radiosensitivity and chemosensitivity of glioblastoma cells through the inhibition of the ATM signaling pathway. Oncol Rep. 2015 Aug;34(2):943-51. doi: 10.3892/or.2015.4050. Click
It has been 47669 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP